EP2775847A1 - Botanical antimicrobial composition - Google Patents
Botanical antimicrobial compositionInfo
- Publication number
- EP2775847A1 EP2775847A1 EP12846062.3A EP12846062A EP2775847A1 EP 2775847 A1 EP2775847 A1 EP 2775847A1 EP 12846062 A EP12846062 A EP 12846062A EP 2775847 A1 EP2775847 A1 EP 2775847A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- oil
- extract
- benzyl alcohol
- alcohol
- botanical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/22—Lamiaceae or Labiatae [Mint family], e.g. thyme, rosemary, skullcap, selfheal, lavender, perilla, pennyroyal, peppermint or spearmint
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/40—Liliopsida [monocotyledons]
- A01N65/44—Poaceae or Gramineae [Grass family], e.g. bamboo, lemon grass or citronella grass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/382—Vegetable products, e.g. soya meal, wood flour, sawdust
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
Definitions
- compositions comprising antimicrobially effective combinations of benzyl alcohol, essential oils and botanical extracts (including plant extracts and fruit extracts).
- Essential oils are volatile oils obtained from plant or animal sources and are composed of complex mixtures of several constituents, such as monoterpenes and sesquiterpene hydrocarbons, monoterpene and sesquiterpene alcohols, esters, ethers, aldehydes, ketones, oxides and the like. These essential oils and their isolated constituents are frequently utilized as fragrance and flavor agents, and have been widely used in folk medicine for wound healing properties.
- Essential oils of eucalyptus have been found to "possess central and peripheral analgesic effects as well as neutrophil-dependent and independent anti-inflammatory activities" (Silva et al., 2003, J. Ethnopharmacol. 89(2-3);277-283), and similar activity has been observed in essential oils from Lavendula angustifolia Mill. (Hajhashemi et al., 2003, J. Ethnopharniacol. 89(i):67 ⁇ 71). Essential oils have been demonstrated to exhibit antibacterial (Bezic et al., 2003, Phytother. Res.
- Virucidal activity of essential oils has also been observed, including direct virucidal effects against Herpes simplex viruses types 1 and 2 (Garcia et al., Phytother. Res. 17(9): 1073- 1075; Minami et al., 2003, Microbial Immunol. 47(a):681-684; Schuhmacher et al, 2003, Phytomedicine 10:504- 510).
- compositions comprising a quaternary ammonium compound and an essential oil (or active component thereof).
- compositions comprising an essential oil (or component thereof) where zinc salts are added to inhibit irritation associated with essential oils.
- Examples of such patent applications include United States Patent Application Publication No. 20040102429 by Modak et al., published May 27, 2004 and United States Patent Application Publication No. 20050238602 by Modak et al., published October 27, 2005, now U.S. Patent No. 7,435,429.
- a non-toxic mold inhibitor which may be a plant extract such as an essential oil.
- United States Patent No. 5,310,546 by Douglas, issued May 10, 1994 relates to a mouth rinse preparation comprising hydrogen peroxide, zinc chloride, sodium citrate, sodium lauryl sulfate, citric acid and ethanol and optionally an essential oil which is a denaturing agent.
- BiON offers several skin care products comprising citric acid, botanicals, and other agents for topical use (San Diego, CA, US).
- Johnson et al. (U.S. Pat. No. 6,319,958 and US20020165130) relates to the use of sesquiterpenoids to promote uptake of exogenous antimicrobial compounds.
- a related article discloses the use of sesquiterpenoids, such as nerolidol, farnesol, bisabolol and apritone, in enhancing bacterial permeability and susceptibility to exogenous antimicrobial compounds, suggesting that sesquiterpenoids have a non-specific and general effect (Brehm-Stecher et al, 2003, Antimicrobial Agents and Chemotherapy, 47(10):3357-3360).
- nerolidol, farnesol, bisabolol and apritone enhanced the susceptibility of S. aureus to the antibiotics erythromycin, gentamicin, vancomycin, ciproflaxin, clindamycin, and tetracycline.
- United States Patent No. 6,753,305 by Raso and Caselli, issued June 22, 2004, relates to a hard surface disinfectant comprising up to 20 percent of cinnamon oil or a component thereof, 0.01-5 percent of an organic acid, and optionally an additional essential oil.
- topical ointments have been used. These ointments have incorporated silver sulfadiazine (U.S. Patent No. 3,761 ,590, incorporated herein by reference) or various antibiotics. A topical ointment for burns has also been reported which contains a combination of silver salts and norfloxocin, a quinoline antibiotic, or its salts (U.S. Patent No. 4,404,197, incorporated hereby by reference). In the case where the antibiotic is silver norfloxocin, U.S. Patent No. 4,404,197 reports a synergistic enhancement of activity. U.S. Patent No. 5,374,432 relates to topical anti -infective ointments containing an antibiotic, silver salt, and sterile carrier. These compositions were found to not only provide improved antimicrobial efficacy, but also reduced incidence of microbial resistance.
- U.S. Patent No. 6,987,133 relates to a topical preparation containing silver sulfadiazine dispersed or solubilized in a cream or lotion base matrix which can be sprayed directly on the burn wound.
- European Patent No. EP0653214 relates to a topical antibacterial preparation containing silver sulfadiazine and collagen for the treatment of infected hands and for the advancement of their healing. There is a continuing desire for an antimicrobial or wound healing composition that are non- irritating, safe, and effective for repeated use in various professional and non-professional settings. 3. SUMMARY
- compositions comprising antimicrobially effective low concentrations of benzyl alcohol, one or more essential oil and one or more botanical extract, in certain embodiments, compositions are provided having antimicrobial active agents that are substantially or essentially entirely derived from natural sources, thereby allowing the user to avoid harsh and/or toxic chemicals. This may be particularly advantageous in products for use by or on children or pets or for use in households or other environments occupied by children or animals.
- an antimicrobial composition comprising benzyl alcohol (from about 0.1 %(w/w) to about 10% (w/w)), one or more essential oil such as but not limited to lemongrass oil, cinnamon oil, thyme oil, galanga oil, orange oil, pomegranate oil, curry leaf oil and combinations thereof (from about 0.02%(w/w) to about 1.0% (w/w)), and one or more botanical extract such as wasabi extract, grapefruit seed extract, honey suckle extract, cedarwood extract, pomegranate extract, Echinacea extract, aspen bark extract, willow bark extract , citrus extract, Brahmi extract and combinations there of (from about 0.1 %(w/w)- 1.0% (w/w)).
- essential oil such as but not limited to lemongrass oil, cinnamon oil, thyme oil, galanga oil, orange oil, pomegranate oil, curry leaf oil and combinations thereof (from about 0.02%(w/w) to about 1.0% (w/w)
- botanical extract such as wasabi
- Optional ingredients include one or more sesquiterpenoid such as farnesol, nerolidol, bisabolol, apritone, citral and combinations thereof (from about 0.03%(w/w) to about 2% (w/w)), one or more plant derived alcohol (from about 5%(w/w) to about 20% (w/w)), one or more natural organic acid such as a fruit acid, benzoic acid, salicylic acid and combinations thereof (from about 0.02%(w/w) to about 2.0%o(w/w)), and vegetable glycerin.
- sesquiterpenoid such as farnesol, nerolidol, bisabolol, apritone, citral and combinations thereof (from about 0.03%(w/w) to about 2% (w/w))
- one or more plant derived alcohol from about 5%(w/w) to about 20% (w/w)
- one or more natural organic acid such as a fruit acid, benzoic acid, salicylic acid
- an antimicrobial composition comprising:
- composition from about 0.1%(w/w) to about 4% (w/w) sesquiterpenoid, wherein the composition does not comprise an alkanediol.
- an antimicrobial composition comprising:
- (c) from about 0.5%(w/w) to about 10% (w/w) botanical extract selected from the group consisting of wasabi extract, honeysuckle extract, cedar wood extract, aspen bark extract, willow bark extract, tobacco extract, and combinations thereof.
- an antimicrobial composition comprising:
- composition does not comprise an alkanediol.
- an antimicrobial composition comprising
- composition further comprises from about 0.2%(w/w) to about 2.0% (w/w) of one or more botanical selected from the group consisting of wasabi extract, grapefruit extract, citrus extract, honeysuckle extract, aloe gel, and aloe leaf juice.
- the composition further comprises from about 0.1%(w/w) to about 0.5% (w/w) zinc oxide.
- the composition further comprises from about 0.2%>(w/w) to about 0.5% > sodium benzoate.
- the composition further comprises from about 0.1%(w/w) to about 1.0 % (w/w) pentanediol.
- the composition further comprises grapefruit seed or another citrus extract, for example, at a concentration from about 0.3%(w/w) to about 1.0% (w/w).
- the composition further comprises one or more of Vitamin E and/or Vitamin C, for example with each being at a concentration from about 0.02%(w/w) to about 0.2% (w/w).
- the composition further comprises a sesquiterpenoid or a mixture of sesquiterpenoids, for example at a concentration from about 0.3%(w/w) to about 2.0% (w/w).
- the composition does not comprise an antibiotic or antiseptic agent which is a biguanide, a chlorinated phenol, or a quaternary ammonium compound.
- the composition does not comprise phenylethanol.
- the composition does not comprise phenoxyethanol.
- the composition does not comprise polymixin, miconazole, fluconazole, itriconazole, or keoconazole.
- the composition does not comprise neomycin.
- the composition does not comprise bacitracin.
- the composition does not comprise povidone iodine or other iodine-containing compounds.
- an antimicrobial composition comprising
- composition further comprises from about 0.2%(w/w) to about 2.0% (w/w) of one or more botanical selected from the group consisting of wasabi extract, grapefruit extract, citrus extract, honeysuckle extract, aloe gel, and aloe leaf juice.
- the composition further comprises from about 0.5%(w/w) to about 3.0%o (w/w) pentylene glycol.
- the composition further comprises from about 0.5%(w/w) to about 2.0% (w/w) of a cationic surfactant.
- the composition does not comprise an antibiotic or antiseptic agent which is a biguanide, a chlorinated phenol, or a quaternary ammonium compound.
- the composition does not comprise phenylethanol. In certain subsets of this embodiment, the composition does not comprise polymixin, miconazole, fluconazole, itriconazole, or keoconazole. In certain subsets of this embodiment, the composition does not comprise neomycin. In certain subsets of this embodiment, the composition does not comprise bacitracin. In certain subsets of this embodiment, the composition does not comprise povidone iodine or other iodine-containing compounds.
- an antimicrobial composition comprising
- the composition does not comprise an antibiotic or antiseptic agent which is a biguanide, a chlorinated phenol, or a quaternary ammonium compound.
- the composition does not comprise phenoxyethanol.
- the composition does not comprise polymixin, miconazole, fluconazole, itriconazole, or keoconazole.
- the composition does not comprise neomycin. In certain subsets of this embodiment, the composition does not comprise bacitracin. In certain subsets of this embodiment, the composition does not comprise povidone iodine or other iodine-containing compounds. In certain non-limiting embodiments, a disinfectant is provided comprising
- a wound-healing composition comprising
- a surface disinfectant comprising:
- aliphatic alcohol for example, but not limited to, a mixture of aliphatic alcohols, for example mixtures of ethanol and propanol or butanol, e.g., SDA 3C or SDA 40B
- aliphatic alcohol for example, but not limited to, a mixture of aliphatic alcohols, for example mixtures of ethanol and propanol or butanol, e.g., SDA 3C or SDA 40B
- a surface disinfectant comprising:
- a cleaning composition comprising from about l%(w/w) to about 5% (w/w) lemongrass oil, from about 0.1%(w/w) to about 1 % (w/w) pine oil, and from about 5%(w/w) to about 20% (w/w) citric acid.
- the compositions may be utilized in personal care products such as soaps, scrubs, cosmetics, topical creams and lotions, wound care products, burn wound cream, decubitous ulcer cream (with antiinflammatory botanicals and the use of silver sulfadiazene as an anti-microbial agent), rapidly acting skin disinfectants, disinfecting wipes, and veterinary products, such as antimicrobial lotion for mastitis, teat dip, and therapeutic ointments.
- personal care products such as soaps, scrubs, cosmetics, topical creams and lotions, wound care products, burn wound cream, decubitous ulcer cream (with antiinflammatory botanicals and the use of silver sulfadiazene as an anti-microbial agent), rapidly acting skin disinfectants, disinfecting wipes, and veterinary products, such as antimicrobial lotion for mastitis, teat dip, and therapeutic ointments.
- the compositions of the application may be used in concentrations from about 1% to about 10%o in personal care products or topical creams.
- the compositions may be utilized in
- compositions disclosed herein comprise benzyl alcohol, at a concentration (percent weight/weight, "% w/w") from about 0.05%(w/w) to about 60 % w/w, or from aboput 0.5%(w/w) to about 50%(w/w), or from about 0.5%(w/w) to about 50%(w/w); or from about 0.5%(w/w) to about 2.0%(w/w), or from about 0.1 %(w/w) to about 2.0% (w/w), or from about 0.1%(w/w) to about 0.5%(w/w), or from about 0.5%(w/w) to about 5%(w/w), or from about 5.0%(w/w) to about 20% (w r /w), including but not limited to about 0.05%(w/w , 0.1 %(w/w) , 0.5%(w/w),1 .0%(w/w), 2.0%(w/w), 3.0%(w/w), 4.0%(w/w), 5.0%(w
- compositions disclosed herein comprise benzyl alcohol, at a concentration of between about 0.1 and about 0.5 % w/w; or between about 0.1 and about 0.45 % w/w; or between about 0.1 and about 0.4 % w/w; or between about 0.1 and about 0.35 % w/w; or between about 0.1 and about 0.3 % w/w; or between about 0.1 and about 0.25 % w/w; or between about 0.1 and about 0.2 % w/w; or between about 0.1 and about 0.15 % w/w.
- Benzyl alcohol for use in the compositions disclosed herein may be produced synthetically or may be obtained from one or more natural plant (botanical) source.
- Essential oils are volatile oils obtained from plant or animal sources, or their synthetic equivalents, and are composed of complex mixtures of several constituents such as monoterpenes and sesquiterpene hydrocarbons, monoterpene and sesquiterpene alcohols, esters, ethers, aldehydes, ketones, oxides and the like.
- EOs include, but are not limited to, cinnamo oil (e.g., cinnamon leaf oil or cinnamon bark oil), basil oil, bergamot oil, clary sage oil, ylang-ylang oil, neroli oil, sandalwood oil, frankincense oil, ginger oil, peppermint oil, lavender oil, jasmine absolute, geranium oil bourbon, spearmint oil, clove oil, patchouli oil, rosemary oil, rosewood oil, sandalwood oil, tea tree oil, vanilla oil, lemongrass oil, oregano oil, thymol, galangal oil, cedar wood oil, balsam oils, tangerine oil, Hinoki oil, Hiba oil, ginko oil, eucalyptus oil, lemon oil, orange oil, sweet orange oil, pomegranate seed oil, pomegranate oil, manuka oil, citronella oil, curry leaf oil, and calendula oil.
- cinnamo oil e.g., cinnamon leaf oil or
- ICs Individual constituents of essential oils may be isolated from the oil (natural) or may be entirely or partially chemically synthetic, and include, but are not limited to, thyme, oregano, curcumin, 1-citronellol, a-amylcinnamaldehyde, lyral, geraniol, faniesol, hydroxycitronellal, isoeugenol, eugenol, camphor, eucalyptol, linalool, citral, thymol, limonene and menthol.
- Further examples of ICs include sesquiterpenoid compounds, which may be the active compounds in the essential oils.
- Sesquiterpenoid compounds containing 15 carbons, are formed bios>Tithetically from three 5 -carbon isoprene units.
- Sesquiterpenoid compounds include, but are not limited to, farnesol, nerolidol, bisabolol, apritone, chamazulene, santalol, zingiberol, carotol, and caryophyllen.
- an IC is selected from the (non-limiting) group consisting of camphor, curcumin, alpha-pinene, constituents of cinnamon leaf oil such as, cinnamaldehyde, cinnamyl acetic ester, cinnamic acid, ethyl cinnamate, methyl chavicol, linalool, beta-caryophyllene, and eugenol; constituents of lemongrass oil such as d-limonene, geranyl acetate, nerol, geraniol, citral, and/or myrcene; constituents of citronella oil such as geraniol, citronellol, citronellal, geranyl acetate, limonene, methyl isou
- the EO is selected from one or more EO from the group consisting of cinnamon oil (CO) (bark or leaf), lemongrass oil (LGO), and basil oil (BO), all of which have little to no fragrance, or nonfragrant oils such as pomegranate seed oil (PSO).
- CO cinnamon oil
- LGO lemongrass oil
- BO basil oil
- PSO pomegranate seed oil
- Calendula contains high amounts of flavonoids, plant-based antioxidants that protect the body against cell-damaging free radicals. It appears to have anti-inflammatory, antiviral, and antibacterial effects. Animal studies show that calendula accelerates wound healing, possibly by increasing blood flow to the wounded area and by helping the body produce collagen proteins, which are used to heal skin and connective tissue. 4.3 BOTANICAL EXTRACTS
- Botanical extracts include plant, herbal, and fruit extracts, w r hich are not "essential oils” as noted above.
- the botanical extracts utilized herein include but are not limited to wasabi, honeysuckle, cedar wood, aspen bark, willow bark, Brahmi (Bacopa monnieri) extract, citrus extract Camellia sinensis (green tea), grapes, pomegranate, Echinacea, Centella Asiatica, Elderflower, Irish moss, Mallow, soap bark, Yucca, Clary sage, oregano, thyme, curcumin compounds, resveratrol (polyphenols compound from grape, berries, etc.) vetivert and mixtures thereof.
- the botanical utilized to obtain the botanical extract may be obtained from any of the plant parts including the leaves, pulp, seeds, or stems, fruit and fruit seeds, as well as the whole plant.
- Herbal extracts can be, for example, standardized extracts that are dispersible and/or soluble in aqueous medium.
- herbal extracts include, without limitation, extracts of chamomile, rosemary, aloe, nettle, Centella asiatica, ginkgo biloba, betula, and witch hazel. Such extracts may be delivered in a carrier such as water, propylene glycol, hydroalcohol, glycerine, or butylene glycol. Additional extracts with nutritional quality can be used, including, without limitation, green tea, white tea, grape skin, grape seed, resveratrol grapefruit, grapefruit seed, grapefruit peel, citrus fruits (other than grapefruit extract) bilberry, blueberry, Ginkgo biloba, soy isoflavones, soy extract, fermented soy protein, black cohosh, St.
- Botanical extracts can be obtained from, for example, Active Organics (Lewisville, Tex.), New Age Botanicals (Garland, Tex.), Triarco Industries (Wayne, N.J.), and Aloecorp (Broomfield, Colo.).
- nonfragrant botanicals include pomegranate seed oil (PSO), mixtures of edible plant extract Kefiprotect (KP), and tetrahydrocurcuminoid (THC).
- Turmeric and curcuminoids have been documented to have anti inflammatory, antioxidant and wound healing properties,
- the following curcuminoids can be used in topical creams, tetrahydrocurcumin, tetrahydrodemethoxycurcumin, tetrahydrobisdemethoxycurcumin, and mixtures thereof.
- Additional examples of botanical extracts include coconut derived phospholipid (Arlasik phospholipid PTM), natural blends of fatty acids which mimic those found in the stratum corneum, mixture of fatty acids with pigments such as carotenes, carotenoids or phytosterols that are known to facilitate repair to damaged skin, and the like.
- useful botanical extracts include avocado, which contains the sterol sitosterol; carrot, which contains beta carotene; sesame oil which contains a mixture of saturated and unsaturated fatty acids, and brazil nut oil. Because of its broad distribution of fatty acids, extracts such as brazil nut oil, can outperform single fatty acids with respect to incorporation into the lipid lamellar structures.
- Brazil nut oil (BNO) originates from the harvested fruit from the South American rain forest tree: Bertholletia excelsa.
- Botanical extracts also include flavonoids and terpenoids.
- the flavonoids contemplated by the present subject matter include, but are not limited to, turin, quercetin, hesperidin, and naringin.
- Terpenoids contemplated by the present subject matter include, but are not limited to, monoterpenes, sesquiterpenes, and diterpenes.
- the botanical extract is selected, from one or more extract selected from the group consisting of grapefruit seed extract (GSE), pomegranate seed oil (PSO), citrus fruit extract, or mixtures of edible plant extract Kefiprotect (KP), coconut derived phospholipid (Arlasik phospholipid PTM), and tetrahydrocurcuminoid (THC).
- GSE grapefruit seed extract
- PSO pomegranate seed oil
- KP vegetable plant extract
- KP coconut derived phospholipid
- THC tetrahydrocurcuminoid
- compositions disclosed herein comprise one or more sesquiterpenoid selected from the group consisting of farnesol, nerolidol, bisabolol, apritone, citral and combinations thereof.
- sesquiterpenoid selected from the group consisting of farnesol, nerolidol, bisabolol, apritone, citral and combinations thereof.
- bifunctional alcohols which may be used according to the present subject matter are alkanediols.
- alkanediols include, but are not limited to, propanediol, butanediol, dodecanediol, decanediol, nonanediol, octanediol, heptanediol, hexanediol, and pentanediol.
- the alkanediols have a carbon backbone of between 3 and 25 carbon atoms, including but not limited to 1,9 Nonanediol, 1,2-Decanediol, 1,10-Decanediol, 1,11-Undecanediol, 1 ,2-Dodecanediol, 1 ,12 Dodecanediol, Cyclododecanediol, 1,13-Tridecanediol, 1 ,2- Tetradecanediol, 1 , 14-Tetradecanediol, 1 , 15-Pentadecanediol, 1 , 16-Hexadecanediol, 1 ,17-Heptadecanediol, 1 ,18-OctadecanedioI, 1,19-Nonadecanediol, 1,20- Eicosanediol, 1,21-H
- an alkanediol is obtained from a natural product. In certain embodiments an alkanediol is chemically synthesized.
- compositions of the present subject matter may include one or more solvent, including but not limited to solvent(s) selected from the group consisting of water, alcohols, plant derived alcohols, glycols, glycerol, glycerine, octoxyglycerin, diglycerol, propylene glycol, dipropylene glycol, and vegetable oils.
- solvent(s) selected from the group consisting of water, alcohols, plant derived alcohols, glycols, glycerol, glycerine, octoxyglycerin, diglycerol, propylene glycol, dipropylene glycol, and vegetable oils.
- non-alkanediol alcohols for solubilization are aliphatic alcohols having between about 1 and 8 carbon atoms such as methanol, ethanol, n-propanol, isopropyl alcohol, 2-methyl-2 propanol, hexanol, or combinations thereof.
- Aromatic alcohols for example, but not by way of limitation, phenoxyethanol, benzyl alcohol, 1 -phenoxy-2-propanol, and/or phenethyl alcohol, may also optionally be used in combination with aliphatic alcohols.
- Aromatic alcohols for example, but not by way of limitation, include phenoxyethanol, benzyl alcohol, l-phenoxy-2 -propanol, and/or phenethyl alcohol, for example at a concentration of between about 0.5 and 5 % (weight/weight) may also optionally be used in combination with aliphatic alcohols.
- a further solvent which optionally may be comprised in a composition of the application is isopropyl myristate.
- Additional aliphatic alcohols include ethanol, denatured alcohol (SDA 40B and SDA 3C) and isopropanol.
- Compositions comprising combinations of benzyl alcohol, botanicals, and 1 ,3 propanediol and its derivatives such as 2-methyl-l-nitro 1 ,3-propanediol (Diol) or 2-Hydroxymethyl 2-nitro 1,3-propanediol (Triol), may further contain cosolvents such as glycerin, octoxyglycerin, alcohol, glycols, butanediol, and phenoxy ethanol.
- cosolvents such as glycerin, octoxyglycerin, alcohol, glycols, butanediol, and phenoxy ethanol.
- the solvent is benzyl alcohol, glycerin, or a combination thereof
- the solvents are used at concentrations ranging from about 0.001 % to about 90% (w/w), or from about 1 % to about 85% (w/w), or from about 10% to about 70% (w/w), or from about 30% to about 65% (w/w). In alternative embodiments, the concentration ranges range from about 5% to about 90% (w/w), preferably from about 30% to about 90%. (w/w), and more preferably from about 40%) to about 80% (w/w).
- the solvent is a natural product, for example, benzyl alcohol derived from the Cassia plant.
- the solvent is benzyl alcohol or its derivatives, e.g., hydroxy! benzyl alcohol, nitro benzyl alcohol, or other derivatives.
- Benzyl alcohol concentrations ranging from about 0.5% to about 10% (w/w), preferably from about 0.5% to about 5% (w/w), more preferably from about 0.5% to about 4% (w/w), have been found to exhibit antimicrobial efficacy with certain botanical organic acids, and in particular fruit acids.
- Alternative embodiments use from about 1.0% to about 5.0% (w/w), or from about 1 % to about 3% (w/w) benzyl alcohol.
- Use of other botanicals and synthetic antimicrobials along with benzyl alcohol and these acids further enhances the activity as discussed in further detail below.
- Natural organic acids such as fruit acids, which may be used according to the application include but are not limited to fruit acid, citric acid, glycolic acid, lactic acid, malic acid, tartaric acid, benzoic acid, salicylic acid, and acetic acid.
- the fruit acid is Multifruit BSC (Arch Chemicals), which is a mixture of lactic, citric, tartaric, glycolic, and malic acid extracted from plants.
- the fruit acid is lactic acid.
- a fruit acid for use in the application may be obtained from its natural source or may be chemically synthesized.
- organic acids which may be used in compositions disclosed herein include but are not limited to benzoic acid and its derivatives including salt forms, for example, a benzyl benzoate, paraamino benzoic acid, nitro benzoic acid, hydroxy! benzoic acid, flurobenzoic acid, and benzyl salicylate.
- Fruit acids may be used according to the application to assist in the controlled release of the silver compound.
- Non-limiting examples of fruit acids include but are not limited to citric acid, glycolic acid, lactic acid, malic acid, tartaric acid and acetic acid.
- the fruit acid is Multifont BSC (Arch Chemicals), which is a mixture of lactic, citric, tartaric, glycolic, and malic acid extracted from plants.
- a fruit acid for use in the compositions of the present subject matter may be obtained from its natural source or may be chemically synthesized.
- the fruit acid is lactic acid or citric acid.
- concentrations of fruit acids ranges from about 0% to about 70% (w/w), or from about 5% to about 70% (w/w), or from about 5% to about 20% (w/w), or from about 10% to about 20% (w/w).
- the concentrations range from about 0% to about 20% (w/w), or from about 0% to about 40% (w/w), or from about 0.1% to about 20% (w/w), or from about 0.2% to about 4% (w/w), or from about 0.5% to about 4% (w/w), or from about 2% to about 4% (w/w).
- the concentrations of natural organic acid present in a composition for use range from about 0.2% to about 2% (w/w), or from about 0.2 to about 1% (w/w).
- the natural organic acids are present in a composition for use at concentrations ranging from between about 0.01% to about 5%> (w/w), or from about 0.01% to about 4% (w/w), or from about 0.01% to about 3% (w/w), or from about 0.01% to about 2% (w/w), or from about 0.01% to about 1% (w/w), or from about 0.02% to about 5% (w/w), or from about 0.02% to about 4% (w/w), or from about 0.02% to about 3% (w/w), or from about 0.02% to about 2% (w/w), or from about 0.02% to about 1% (w/w), or from about 0.05% to about 2.0% (w/w), or from about 0.1% to about 2.0% (w/w).
- personal care product compositions comprising benzyl alcohol and one or more essential oil and/or one or more botanical extract, for example a plant or fruit extract.
- the pH of personal care products is between about 3.0 and 6.0.
- Non-limiting examples of personal care products which may utilize the compositions of the present subject matter include bar soap, liquid soap (e.g., hand soap), hand sanitizer (including rinse off and leave-on alcohol based and aqueous- based hand disinfectants), preoperative skin disinfectant, cleansing wipes, disinfecting wipes, body wash, acne treatment products, antifungal diaper rash cream, antifungal skin cream, shampoo, conditioner, cosmetics (including but not limited to liquid or powder foundation, liquid or solid eyeliner, mascara, cream eye shadow, tinted powder, "pancake” type powder to be used dry or moistened, etc.) deodorant, antimicrobial creams, body lotion, hand cream, topical cream, aftershave lotion, skin toner, mouth wash, toothpaste, sunscreen !otion, and baby products such as, but not limited to, cleansing wipes, baby shampoo, baby soap, and diaper cream.
- liquid soap e.g., hand soap
- hand sanitizer including rinse off and leave-on alcohol based and aqueous-
- wound care items such as, but not limited to, wound healing ointments, creams, and lotions, wound coverings, burn wound cream, bandages, tape, and steri-strips, and medical articles such as medical gowns, caps, face masks, and shoe-covers, surgical drops, etc.
- Additional products inc!ude are not limited to oral products such, as mouth rinse, toothpaste, and dental floss coatings, veterinary and pet care products, preservative compositions, and surface disinfectants including solutions, sprays or wipes.
- Personal care compositions provided herein may further comprise one or (preferably) more than one component selected from the group consisting of emollients, stabilizing agents, thickening agents, humectants, anti-inflammatory agents, antimicrobial agents, neutralizing agents, surfactants, water, silicone polymers, alcohols, and hydrogels, as well as additional components as may be known in the art.
- emollients emollients
- stabilizing agents e.g., thickening agents, humectants, anti-inflammatory agents, antimicrobial agents, neutralizing agents, surfactants, water, silicone polymers, alcohols, and hydrogels
- humectants e.g., humectants
- anti-inflammatory agents e.g., antimicrobial agents, neutralizing agents, surfactants, water, silicone polymers, alcohols, and hydrogels
- neutralizing agents e.g., surfactants, water, silicone polymers, alcohols, and hydrogels
- a personal care product may comprise an emollient, for example PEG 20 almond glycerides, Probutyl DB-10, Glucam P-20, Glucam E-10, Glucam P-10, Glucam E-20, Glucam P ⁇ 20 distearate, glycerin, propylene glycol, octoxyglycerin, cetyl acetate, acetylated lanolin alcohol (e.g.
- an emollient for example PEG 20 almond glycerides, Probutyl DB-10, Glucam P-20, Glucam E-10, Glucam P-10, Glucam E-20, Glucam P ⁇ 20 distearate, glycerin, propylene glycol, octoxyglycerin, cetyl acetate, acetylated lanolin alcohol (e.g.
- cetyl ether e.g., PPG- 10
- myristyril ether e.g., PPG-3
- hydroxylated milk glycerides e.g., Cremeral HMG
- polyquaternium compounds e.g., U-care compounds
- copolymers of dimethyl dialyl ammonium chloride and acrylic acid e.g., Merquat
- dipropylene glycol methyl ethers e.g., Dowanol DPM, Dow Corning
- polypropylene glycol ethers e.g., Ucon 50-HB-600, Union Carbide
- silicon polymers e.g., Ucon 50-HB-600, Union Carbide
- emollients may include hydrocarbon-based emollients such as petrolatum or mineral oil, fatty ester-based emollients, such as methyl, isopropyl and butyl esters of fatty acids such as isopropyl palmitate, isopropyl myristate, isopropyl isostearate, isostearyl isostearate, diisopropyl sebacate, and propylene dipelargonate, 2-ethylhexyl isononoate, 2-ethylhexyI stearate, Ci 2 - C] 6 fatty alcohol lactates such as cetyl lactate and lauryl lactate, isopropyl lanolate, 2- ethylhexyl salicylate, cetyl myristate, oleyl myristate, oleyl stearate, oleyl oleate, hexyl laurate, and isohexyl laurate
- a personal care product may comprise a stabilizing agent such as an antioxidant, for example but not limited to vitamin C (ascorbic acid) and/or vitamin E (tocopherol), and/or a surfactant, for example but not limited to incromide or silicone-based surfactants (Masil SF- 19, BASF).
- a stabilizing agent such as an antioxidant, for example but not limited to vitamin C (ascorbic acid) and/or vitamin E (tocopherol)
- a surfactant for example but not limited to incromide or silicone-based surfactants (Masil SF- 19, BASF).
- a personal care product may comprise a thickening and/or gelling agent such as stearyl alcohol, cationic hydroxy ethyl cellulose (Ucare; JR30), hydroxy propyl methyl cellulose, hydroxy propyl cellulose (Klucel), chitosan pyrrolidone carboxylate (Kytamer), behenyl alcohol, zinc stearate, emulsifying waxes, including but not limited to Incroquat and Polawax, an addition polymer of acrylic acid, a resin such as Carbopol® ETDTM 2020, guar gum, acacia, acrylates/steareth-20 methacrylate copolymer, agar, algin, alginic acid, ammonium acrylate co-polymers, ammonium alginate, ammonium chloride, ammonium sulfate, amylopectin, attapulgite, bentonite, C9-15 alcohols
- the gelling agents used in vehicles may be natural gelling agents such as natural gums, starches, pectins, agar and gelatin. Often, the gelling agents are based on polysaccharides or proteins Examples include but are not limited to guar gum, Xanthum gum, Alginic acid (E400), sodium alginate (E401 ), potassium alginate (E402), ammonium alginate (E403 alkanediol, may further comprise a humectant, such as, for example, glycerin, 1-2-propyIene glycol, dipropylene glycol, polyethylene glycol, 1,3-butylene glycol, or 1,2,6-hexanetriol.
- a humectant such as, for example, glycerin, 1-2-propyIene glycol, dipropylene glycol, polyethylene glycol, 1,3-butylene glycol, or 1,2,6-hexanetriol.
- one or more additional antimicrobial agent may be comprised, for example, where such antimicrobial agent may be selected from the group consisting of silver salts, iodophors, iodine, benzoic acid, dihydroacetic acid, propionic acid, sorbic acid, methyl paraben, ethyl paraben, propyl paraben, butyl paraben, cetrimide, benzalkonium chloride, dequalinium chloride, chlorhexidine, chloroeresol, chlorxylenol, benzyl alcohol, bronopol, chlorbutanol, phenoxyethanol, phenylethyl alcohol, 2,4-dichlorobenzyl alcohol, thiomersal, clindamycin, erythromycin, benzoyl peroxide, mupirocin, bacitracin, polymyxin B, neomycin, triclosan, parachlorometaxylene, foscarnet,
- a personal care product may comprise a neutralizing agent to neutralize carboxyl groups present in one or more other component, such as carboxyl groups in a thickening agent.
- Suitable neutralizing agents include diisopropylamine and triethanolarnine.
- the composition may comprise a surfactant.
- the surfactant may be an anionic surfactant, a cationic surfactant, an ampholytic surfactant, or a nonionic surfactant.
- nonionic surfactants include polyethoxylates, fatty aicohols (e.g., ceteth-20 (a cetyl ether of polyethylene oxide having an average of about 20 ethylene oxide units) and other "BRIJ®" nonionic surfactants available from ICI Americas, Inc. (Wilmington, DE)), cocamidopropyl betaine, alkyl phenols, fatty acid esters of sorbitol, sorbitan, or polyoxyethylene sorbitan.
- a specific non-limiting example of a non-ionic surfactant is Glucopon® 215 (Cognis), an aqueous solution of alkyl polyglycosides based on a natural fatty alcohol C8-C10.
- Suitable anionic surfactants include ammonium lauryl sulfate and lauryl ether sulfosuccinate.
- a personal care product may comprise water.
- a compositions used in a personal care product may comprise a hydrogel comprising, for example, a compound such as hydroxypropylmethyl cellulose, cationic hydroxyethyl cellulose (U-care polymers), ethyl cellulose, hydroxypropyl cellulose, hydroxymethyl cellulose, carboxy methyl cellulose, polyethylene oxide (polyox resins), and chitosan pyrrolidone carboxylate (Kytomer PC).
- a compound such as hydroxypropylmethyl cellulose, cationic hydroxyethyl cellulose (U-care polymers), ethyl cellulose, hydroxypropyl cellulose, hydroxymethyl cellulose, carboxy methyl cellulose, polyethylene oxide (polyox resins), and chitosan pyrrolidone carboxylate (Kytomer PC).
- a personal care product may comprise an alcohol or a mixture of alcohols, for example, ethanol, isopropyl alcohol, n-propyi alcohol, and mixtures thereof; fatty alcohols, including, but not limited to, cetyl alcohol, myristol alcohol, stearyl alcohol, octyl alcohol, decyl alcohol and lauryl alcohol, and mixtures thereof; and hexanol.
- alcohols for example, ethanol, isopropyl alcohol, n-propyi alcohol, and mixtures thereof
- fatty alcohols including, but not limited to, cetyl alcohol, myristol alcohol, stearyl alcohol, octyl alcohol, decyl alcohol and lauryl alcohol, and mixtures thereof
- hexanol for example, ethanol, isopropyl alcohol, n-propyi alcohol, and mixtures thereof.
- compositions used in a personal care product may comprise a silicone polymer, for example one or more than one polydiinethylsiloxane polymer (Dow Corning 225 Silicone Fluid), dimethiconol fluid in dimethicone (Dow Corning 1403 Silicone Fluid), cyciomefhicone and dimethicone copolyl (Dow Coming 3225C Silicone Fluid), and silicone glycol (BASF 1 066 DCG polyol).
- a silicone polymer for example one or more than one polydiinethylsiloxane polymer (Dow Corning 225 Silicone Fluid), dimethiconol fluid in dimethicone (Dow Corning 1403 Silicone Fluid), cyciomefhicone and dimethicone copolyl (Dow Coming 3225C Silicone Fluid), and silicone glycol (BASF 1 066 DCG polyol).
- a compositions used in a personal care product may comprise an emollient solvent such as a glycidyl ether having an alkyl chain up to and including 18 carbon molecules and ethoxylates and propoxylates thereof, a glyceryl ether having an alkyl chain up to and including 18 carbon molecules and ethoxylates and propoxylates thereof, a mono- or diglyceryl ether having an alkyl chain up to and including 18 carbon molecules and ethoxylates and propoxylates thereof, ethoxylate and propoxylate ethers, ethoxy diglycol esters, ethyl hexyl alcohol propoxylate, and propylene glycol esther ethoxylates and propoxylates, and Arlamol (Alias).
- an emollient solvent such as a glycidyl ether having an alkyl chain up to and including 18 carbon molecules and ethoxylates and propoxylates thereof, a g
- a composition used in a personal care product may comprise one or more additive such as a dye, fragrance, pH adjuster, including basic pH adjusters such as ammonia, mono-, di- and tri- alkyl amines, mono-, di- and tri-alkanolamines, alkali metal and alkaline earth metal hydroxides (e.g., ammonia, sodium hydroxide, potassium hydroxide, lithium hydroxide, monoethanolamine, triethylamine, isopropylamine, diethanolamine and triethanolamine); acid pH adjusters such as mineral acids and polycarboxylic acids (e.g., hydrochloric acid, nitric acid, phosphoric acid, sulfuric acid, citric acid, glycolic acid, and lactic acid); a vitamin such as vitamin A, vitamin E and vitamin C; a polyamino acid or salt thereof, ethylenediamine tetraacidic acid (EDTA), a preservative such as Germall plus or DMDM hy
- basic pH adjusters such
- a personal care composition has both antimicrobial and anti-inflammatory (AM-AI) activities, and, for example, may be used as a skin cleanser or topical cream.
- AM-AI antimicrobial and anti-inflammatory
- the present subject matter also provides for rapidly acting AMI hand disinfectant lotions.
- GSE Benzyl alcohol
- 1,3 propanediol when used along with the anti inflammatory agent CRMN, edible plant extract (Kefiprotect®) and Pomegranate seed oil (PSO) exhibits additional antimicrobial activity.
- the present subject matter provides for the preparation of topical cream formulations containing anti-irritant, anti-inflammatory agents, gelling agents, and botanicals for minor cuts and wounds.
- Antifungal activity of antifungal agents can be significantly enhanced by the use of a combination of alcohols such as benzyl alcohol, fruit acids, and optionally biguanide and benzalkonium chloride.
- the present subject matter also provides formulations containing GSE, benzyl alcohol, Zemea®, THC, and a coconut based phospholipid for alcohol-based hand sanitizer (AHS) compositions.
- the present subject matter also provides for alcohol free botanical hand disinfectant lotions comprising between about 0.5% and 2% (w/w) benzyl alcohol; between about 0.3% and 2% (w/w) silicone fluid; between about 0.1% and 0.5% (w/w) zinc oxide; between about 0.1% and 2% (w/w) fruit acid, for example, lactic acid or citric acid; between about 0.05% and 1% (w/w) of one or more botanical selected from aloe gel, GSE, citrus extract, wasabi extract, willow bark extract, aspen bark extract and honeysuckle extract; and between about 0.1 % and 0.5% (w/w) of one or more essential oil selected from oregano oil, pomegranate oil, rosemary oil, lemongrass oil and cinnamon oil (e.g., cinnamon leaf oil or cinnamon bark oil).
- Such compositions can optionally comprise between about 0.5% and 2% (w/w) famesol, between about 0.05% and 0.3% (w/w) thymol, and/or between about 0.2% and 1 %
- Non-limiting examples of alcohol free botanical hand disinfectant lotion, formulations are as follows.
- Polowax NF 0.5-2.0 Incroquat TMS 0.5-4.0
- Oregano oil 0.1-0.3 Thymol 0.05-0.3
- Grapefruit seed/other Citrus extract 0.3-1.0
- Wasabi extract 0.1-0.5 Benzoic acid 0.2-0.5 Sodium Benzoate 0.2-0.5 Adjust pH to 5.5-6.0
- a specific non-limiting specific example of an alcohol free botanical hand disinfectant lotion formulation of the present application includes the following formulation.
- a non- limiting general example of an alcohol free botanical hand disinfectant lotion formulation of the present application includes the following formulation.
- a specific non-limiting specific example of an alcohol free botanical hand disinfectant lotion formulation of the present application includes the following formulation.
- Silicone fluid 1.0 Lactic acid 0.2
- a non-limiting ; genera] example of an alcohol free botanical hand disinfectant lotion formulation of the present application includes the following formulation.
- Silicone fluid 0.3-1.0 Lactic acid 0.1-2.0
- a specific non-iimiting specific example of an alcohol free botanical hand disinfectant lotion formulation of the present application includes the following formulation.
- Silicone fluid 1.0 Lactic acid 0.2
- the present subject matter also provides for aqueous botanical hand disinfectant lotions containing benzyl alcohol and botanicals.
- aqueous botanical hand disinfectant lotions containing benzyl alcohol and botanicals A non-limiting general example of such a formulation includes the following.
- Polowax NF 0.5-2.0 lncroquat TMS 0.5-4.0
- Plant based alcohol (SD A40B from corn ) 10-20
- a specific non-limiting specific example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Aqueous Botanical Hand Disinfectant Lotion A Ingredients % w/w
- Plant based alcohol SDA40B from corn
- Pomegranate oil 0.3 Rosemary oil 0.3 Lemongrass oil 0.2 Thymol 0.1
- a non-limiting general example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Aqueous Botanicaf Hand Disinfectant Lotion B Ingredients Range (%w/w)
- a non-limiting specific example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
- a non-limiting general example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Aqueous Botanical Hand Disinfectant Lotion 1 Ingredients _ Range (%w/ )
- a non-limiting specific example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
- a non-limiting general example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Plant based alcohol SDA40B from corn 10-20 Pomegranate oil 0-1.0 Rosemary oil 0-1.0 Lemongrass oil 0.1-0.5
- a non-limiting specific example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Polowax NF 0.5 incroquat TMS 0.5
- a non-limiting general example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
- a non-limiting specific example of an aqueous botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Cinnamon leaf oil 0.1 Bisabolol 0.05
- Cetrimonium chloride 0.5 Adjust pH to 5.5-6.0
- the present subject matter also provides for aqueous botanical hand disinfectant foams containing benzyl alcohol and botanicals.
- a non-limiting general example of such a formulation includes the following.
- Grapefruit seed extract 0.3-1.0
- Solubulizer (Peg-40 hydrogenated Castor oil, Trideceih 9, water) 1-3
- Silicone (silsurf) 0.5-2.0 Adjust pH 4.0-4.5
- a non-limiting specific example of an aqueous botanical hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 2.0 SDA-40 B (natural) 10
- Silicone (silsurf) 1.4 Adjust pH 4.0-4.5
- a non-limiting general example of an aqueous botanical hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 1-3
- Silicone (silsurf) 0.5-2.0 Adjust pH 4.0-4.5
- a non-limiting specific example of an aqueous botanical hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 2.0
- a non-limiting general example of an aqueous botanical hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 1 -3
- a non-limiting specific example of an aqueous botanical hand disin fectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
- a non-limiting general example of an aqueous botanical hand disinfectant foam containing benzyl alcohol, and botanicals of the present application includes the following formulation.
- Grapefruit seed extract 0.3-1.0
- Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 1-3
- Phospholipid PTM (Croda) 0-1.0 Famesol/Bisabolol 0.3-1.0
- a non-limiting specific example of an aqueous botanical, hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 2.0
- Silicone (silsurf) 1 -4 Adjust pH 4.0-4.5
- a non-limiting general example of an aqueous botanical hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Soiubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 1-3
- Plantasol Caprylyl capryl glucoside
- Biowax PEG-8 dimethicone
- Adjust pH 4.0-4.5
- a non-limiting specific example of an aqueous botanical hand disinfectant foam containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Solubulizer (Peg-40 hydrogenated Castor oil, Trideceth 9, water) 1.5
- the present subject matter also provides for natural alcohol foam hand disinfectants containing benzyl alcohol and botanicals.
- a non-limiting general example of such a formulation includes the following.
- a non-limiting specific example of a natural alcohol foam hand disinfectant containing benzyl alcohol and botanicals of the present application includes the following formulation.
- a non-limiting general example of a natural alcohol foam hand disinfectant containing benzyl alcohol and botanicals of the present application includes the following formulation.
- PEG 10 dimethicone (Ultrapure MFB-10) 0.5-3.0
- a non-limiting specific example of a natural alcohol foam hand ismfectant containing benzyl alcohol and botanicals of the present application ncludes the following formulation.
- Phenyl ethanol 1.0 Zemea (1 ,3- Propane diol) 1.0
- the present subject matter also provides for natural alcohol surgical hand disinfectants containing benzyl alcohol and botanicals.
- a non-limiting general example of such a formulation includes the following. Natural Alcohol Surgical Hand Disinfectant
- Sensiva (Ethylhexyl glycerin) 0.05-3.0 Bisaboiol 0.05-0.5
- a non-limiting specific example of a natural alcohol surgical hand disinfectant containing benzyl alcohol and botanicals of the present application includes the following formulation. Natural Alcohol Surgical Hand Disinfectant ingredients % w/w
- the present subject matter also provides for botanical disinfectant soaps containing benzyl alcohol and botanicals.
- a non-limiting general example of such a formulation includes the following.
- Lemongrass oil 0.05-2.0
- a non-limiting specific example of a botanical disinfectant soap containing benzyl alcohol and botanicals of the present application includes the following formulation.
- a non-limiting general example of a botanical disinfectant soap containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Lemongrass oil 0.05-2.0
- a non-limitmg specific example of a botanical disinfectant soap containing benzyl alcohol and botanicals of the present application includes the following formulation.
- a non-limiting general example of a botanical disinfectant soap containing benzyl alcohol and botanicals of the present application includes the following formulation.
- a non-limiting specific example of a botanical disinfectant soap containing benzyl alcohol and botanicals of the present application includes the following formulation.
- Botanical Disinfectant Soap ingredients % w/w
- an anti-fungal, anti-itch composition comprising from about 0.5%(w/w) to about 5% (w/w) benzyl alcohol and one or more compounds selected from the group consisting of :
- an anti-fungal, anti-itch composition is provided, as follows: Ingredient Ranee (%w/w)
- Zinc oxide 0.5-2.0
- a non-limiting general example of an alcohol-free botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application, where a Phase A solution and a Phase B solution are first prepared separately and then mixed, includes the following formulation.
- Silicone fluid Dimethicone200/350 1-3.0 Aloe juice 0.5-2.0 Bisabolol 0.05-0.2
- Oregano oil 0.05-0.2
- a non-limiting specific example of an alcohol-free botanical hand disinfectant lotion containing benzyl alcohol and botanicals of the present application, where a Phase A solution and. a Phase B solution are first prepared separately and then mixed, includes the following formulation.
- a non-limiting general example of an alcohol-free botanical hand disinfectant foam of the present application includes the following formulation.
- Solubulizer (Peg-40 hydrogented 1 -4 Castor oil, Trideceth 9, water)
- Coco amido propyl betaine 0.5-2.0 Adjust pH 4.0-4.5
- a non-limiting specific example of an alcohol-free botanical hand disinfectant foam of the present application includes the following formulation.
- Solubulizer (Peg-40 hydrogented 3.0 Castor oil, Trideceth 9, water)
- Plantasol Caprylyl capryl glucoside
- Biowax PEG-8 dimethicone
- Coco amido propyl betaine Adjust pH- 4.0-4.5
- compositions of the present subject matter may be used to promote wound healing and/or to inhibit surface infections.
- the compositions of the present subject matter may be utilized in products such as topical creams and lotions, wound care products, bum wound cream, decubitous ulcer cream (with anti-inflammatory botanicals and the use of silver sulfadiazene as an anti-microbial agent), and therapeutic ointments.
- the compositions of the present subject matter may also be applied to wound care items, such as, but not limited to, wound healing ointments, wound coverings, burn wound cream, bandages, tape, and steri-strips, and medical articles such as medical gowns, caps, face masks, and shoe-covers, surgical drops, etc.
- a composition may comprise a thickening and/or gelling agent such as stearyl alcohol, cationic hydroxy ethyl cellulose (Ucare; JR30), hydroxy propyl methyl cellulose, hydroxy propyl cellulose (Klucel), chitosan pyrrolidone carboxylate (Kytamer), behenyl alcohol, zinc stearate, emulsifying waxes, including but not limited to Incroquat and Polawax, an addition polymer of acrylic acid, a resin such as Carbopol® ETDTM 2020, guar gum, acacia, acryiates/stearefh-20 methacrylate copolymer, agar, algin, alginic acid, ammonium acrylate co-polymers, ammonium alginate, ammonium chloride, ammonium sulfate, amylopectin, attapulgite, bentonite, C9-15
- the gelling agents used in vehicles may be natural gelling agents such as natural gums, starches, pectins, agar and gelatin. Often, the gelling agents are based on polysaccharides or proteins Examples include but are not limited to guar gum, Xanthum gum, Alginic acid (E400), sodium alginate (E401), potassium alginate (E402), ammonium alginate (E403), calcium alginate (E404, - polysaccharides from brown algae), Agar (E406, a polysaccharide obtained from red seaweeds), Carrageenan (E407, a polysaccharide obtained from red seaweeds), Locust bean gum (E410, a natural gum from the seeds of the Carob tree), Pectin (E440, a polysaccharide obtained from apple or citrus-fruit), and Gelatin (E441 , made by partial hydrolysis of animal collagen).
- guar gum Alginic acid (E400), sodium alginate (
- Various embodiments may comprise a stabilizer.
- sodium perborate is used as the stabilizing agent in an amount ranging from about 0.3 to about 1% w w.
- the application may further comprise a surfactant.
- the surfactant may be an anionic surfactant, a cationic surfactant, an ampho lytic surfactant, or a nonionic surfactant.
- nonionic surfactants include polyethoxylates, fatty alcohols (e.g., ceteth-20 (a cetyl ether of polyethylene oxide having an average of about 20 ethylene oxide units) and other "BRIJ®" nonionic surfactants available from iCI Americas, Inc. (Wilmington, Del.)), cocamidopropyl betaine, alkyl phenols, fatty acid esters of sorbitol, sorbitan, or polyoxyethylene sorbitan.
- Suitable anionic surfactants include ammonium lauryl sulfate and lauryl ether sulfosuccinate.
- Preferred surfactants include lauroyl ethylenediamine triacetic acid sodium salt, Pkironic F87, Masil SF-19 (BASF) and incromide.
- Water used in the formulations described herein is preferably deionized water having a neutral pH.
- the present subject matter provides for a wound healing topical cream containing silver sulfadiazine, an insoluble zinc salt, a soluble zinc salt and calendula oil.
- the present subject matter provides for a wound healing topical cream containing silver sulfadiazine, an insoluble zinc salt, a soluble zinc salt, calendula oil, and anti inflammatory agents such as a curcumin compound.
- Non-limiting examples of cream products may further contain white petrolatum (2-20%), fatty alcohol (2-20%), emollient (1-10%), emulsifying agent (0.5-10%o), humectant (2-15%), preservative (0.1-0.5%)), and deionized or distilled water q.s. 100%.
- Fatty alcohols include stearyl, alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, and other known fatty alcohols.
- Emollients include isopropyl myristate, lanolin, lanolin derivatives, isopropyl palmitate, isopropyl stearate, emu oil, linseed oil and other known emollients.
- Emulsifying agents include sodium mono- oleate and polyoxyl 40 stearate.
- Humectants include propylene glycol, sorbitol, or glycerine or mixture thereof.
- Suitable water soluble preservatives include parabens, sorbic acid, benzoic acid, diazolidinyl urea, and iodopropylbutylcarbamate (GermaR).
- the present subject matter provides for botanical wound healing gel formulation comprising benzyl alcohol and botanicals.
- botanical wound healing gel formulation comprising benzyl alcohol and botanicals.
- a non-limiting general example of such a formulation includes the following. Botanical Wound Healing Gel
Abstract
Description
Claims
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161555367P | 2011-11-03 | 2011-11-03 | |
US201161567372P | 2011-12-06 | 2011-12-06 | |
US201261583482P | 2012-01-05 | 2012-01-05 | |
US201261583505P | 2012-01-05 | 2012-01-05 | |
US201261583998P | 2012-01-06 | 2012-01-06 | |
US13/412,464 US20130230609A1 (en) | 2012-03-05 | 2012-03-05 | Antimicrobial/preservative compositions comprising botanicals |
PCT/US2012/037135 WO2013066403A1 (en) | 2011-11-03 | 2012-05-09 | Botanical antimicrobial composition |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2775847A1 true EP2775847A1 (en) | 2014-09-17 |
EP2775847A4 EP2775847A4 (en) | 2016-01-13 |
Family
ID=48192554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12846062.3A Ceased EP2775847A4 (en) | 2011-11-03 | 2012-05-09 | Botanical antimicrobial composition |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2775847A4 (en) |
JP (1) | JP2015501330A (en) |
CN (1) | CN104039338A (en) |
AU (1) | AU2012333187A1 (en) |
CA (1) | CA2890395C (en) |
IN (1) | IN2014CN04034A (en) |
WO (1) | WO2013066403A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10806144B2 (en) | 2011-11-03 | 2020-10-20 | The Trustees Of Columbia University In The City Of New York | Composition with sustained antimicrobial activity |
CN111803696A (en) * | 2020-07-10 | 2020-10-23 | 中山大学 | Preparation method of patchouli oil nano composite membrane for skin wound repair |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9687429B2 (en) | 2007-06-20 | 2017-06-27 | The Trustees Of Columbia University In The City Of New York | Antimicrobial compositions containing low concentrations of botanicals |
US9981069B2 (en) | 2007-06-20 | 2018-05-29 | The Trustees Of Columbia University In The City Of New York | Bio-film resistant surfaces |
US9511040B2 (en) | 2007-06-20 | 2016-12-06 | The Trustees Of Columbia University In The City Of New York | Skin and surface disinfectant compositions containing botanicals |
US9968101B2 (en) | 2011-11-03 | 2018-05-15 | The Trustees Of Columbia University In The City Of New York | Botanical antimicrobial compositions |
EP2970834A4 (en) * | 2013-03-15 | 2017-05-10 | The Trustees of Columbia University in the City of New York | Broad spectrum natural preservative composition |
BR112015031477A2 (en) * | 2013-06-18 | 2017-07-25 | Colgate Palmolive Co | antimicrobial compositions comprising essential oil combinations |
WO2015123512A1 (en) * | 2014-02-14 | 2015-08-20 | Kemin Industries, Inc. | Antimicrobial Efficacy of an Oregano Oil and Caprylic Acid Blend |
WO2016018475A1 (en) | 2014-07-31 | 2016-02-04 | Kimberly-Clark Worldwide, Inc. | Anti-adherent composition |
AU2015297024A1 (en) | 2014-07-31 | 2017-03-02 | Kimberly-Clark Worldwide, Inc. | Anti-adherent alcohol-based composition |
KR102501943B1 (en) | 2014-07-31 | 2023-03-15 | 킴벌리-클라크 월드와이드, 인크. | Anti-adherent composition |
MX2017002255A (en) * | 2014-09-01 | 2017-05-22 | Colgate Palmolive Co | Zinc-containing compositions with essential oils. |
CN104306212A (en) * | 2014-09-29 | 2015-01-28 | 青岛康合伟业商贸有限公司 | Facial cleanser capable of promoting wound healing |
CN104371826A (en) * | 2014-10-31 | 2015-02-25 | 湖北中烟工业有限责任公司 | Natural cigarette flavoring with antiseptic effect |
WO2016065609A1 (en) * | 2014-10-31 | 2016-05-06 | Kimberly-Clark Worldwide, Inc. | Anti-adherent botanical compositions |
US11319512B2 (en) | 2014-11-18 | 2022-05-03 | Jessica Adelle Gore | Natural edible cleaning composition |
US9534193B1 (en) | 2014-11-18 | 2017-01-03 | Jessica Adelle Gore | Natural edible cleaning composition |
US11207253B2 (en) | 2015-01-28 | 2021-12-28 | Arxada, LLC | Preservative compositions for formulations |
KR101748152B1 (en) | 2015-03-04 | 2017-06-19 | 대한민국 | Anti-microbial agent composition for growth restraint of oak wilt pathogen and Natural anti-microbial agent |
KR102401730B1 (en) | 2015-04-01 | 2022-05-26 | 킴벌리-클라크 월드와이드, 인크. | Fiber base for trapping Gram-negative bacteria |
CN104818140A (en) * | 2015-04-30 | 2015-08-05 | 威莱(广州)日用品有限公司 | Antibacterial dishwashing detergent |
JP2017066071A (en) * | 2015-09-29 | 2017-04-06 | 株式会社マンダム | Cosmetic composition |
WO2017204806A1 (en) | 2016-05-26 | 2017-11-30 | Kimberly-Clark Worldwide, Inc. | Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface |
WO2017223203A1 (en) | 2016-06-22 | 2017-12-28 | Lonza Inc. | Preservative composition for wet wipes |
US11104868B2 (en) | 2016-07-26 | 2021-08-31 | Colgate-Palmolive Company | Liquid cleansing compositions with an antibacterial system and method of manufacturing thereof |
EP3520785A4 (en) * | 2016-10-09 | 2020-05-27 | Shenzhen Eulikan Biotechnology Co., Ltd. | Uses of bacteriostatic agent formula in preparing composition for vaginal use and composition for vaginal use |
CN106719947A (en) * | 2016-11-29 | 2017-05-31 | 福建味道生物科技有限公司 | A kind of environment friendly biological formulation of pesticide |
CN106719948A (en) * | 2016-11-29 | 2017-05-31 | 福建味道生物科技有限公司 | A kind of preparation method of biological pesticide |
JP7220655B2 (en) * | 2016-12-16 | 2023-02-10 | ヴァーテラス ホールディングス エルエルシー | Quaternary amine formulations and uses thereof |
EP3354135A1 (en) * | 2017-01-31 | 2018-08-01 | CuraSolutions GmbH | Antimicrobial composition with reinforced effect for the treatment of liquids containing water |
US20200352991A1 (en) * | 2017-07-27 | 2020-11-12 | The Trustees Of Columbia University In The City Of New York | Polymer films with antimicrobial agents |
CN108186618B (en) * | 2017-08-02 | 2021-03-02 | 成都医学院 | New application of citral and derivatives thereof in preparation of MRSA infectious disease medicines |
CA3075086A1 (en) * | 2017-09-15 | 2019-03-21 | Gojo Industries, Inc. | Antimicrobial composition comprising one or more c1-8 alcohols, a buffer and an enhancer |
CN107647974A (en) * | 2017-10-20 | 2018-02-02 | 福建恒安卫生材料有限公司 | The preparation method of feature compound core body |
CN107875088A (en) * | 2017-11-17 | 2018-04-06 | 东兴市良佳优农林科技有限公司 | Antibacterial hand sanitizer and preparation method thereof |
CN107875087A (en) * | 2017-11-17 | 2018-04-06 | 东兴市良佳优农林科技有限公司 | Moisturizing type antibacterial hand sanitizer and preparation method thereof |
CN107951808A (en) * | 2017-12-24 | 2018-04-24 | 姚佑灿 | A kind of composition of cleaning sterilization |
EP3543325A1 (en) * | 2018-03-19 | 2019-09-25 | Green Impact Holding AG | Organic disinfecting agent |
JP6454805B1 (en) * | 2018-03-26 | 2019-01-16 | 株式会社Adeka | Alcohol preparation and disinfection method using the same |
RU2704038C1 (en) * | 2018-04-25 | 2019-10-23 | Светлана Александровна Чубатова | Basic composition for preparation of biologically active means of human environment treatment |
WO2020017619A1 (en) * | 2018-07-20 | 2020-01-23 | 株式会社 資生堂 | Virus inactivating agent |
RU2691479C1 (en) * | 2018-07-31 | 2019-06-14 | Общество с ограниченной ответственностью Научно-Технический Центр "Химинвест" | Aspen bark processing method |
WO2020094864A1 (en) * | 2018-11-09 | 2020-05-14 | Mother Earth Dermatics (Med) Gmbh | Insect repellent composition |
AU2020220554A1 (en) * | 2019-02-11 | 2021-08-05 | Reckitt Benckiser Health Limited | Topical sanitizing compositions |
CN117562085A (en) * | 2019-02-26 | 2024-02-20 | 大日本除虫菊株式会社 | Sterilization or virus inactivation agent composition and sterilization or virus inactivation efficacy enhancing method |
WO2020174980A1 (en) * | 2019-02-26 | 2020-09-03 | 大日本除蟲菊株式会社 | Sterilization or virus-inactivating agent composition, and method for enhancing efficacy of sterilization or virus inactivation |
CN109646361B (en) * | 2019-02-27 | 2022-03-29 | 山东信得科技股份有限公司 | Composite biological deodorization spray for pets and preparation method thereof |
RU2733718C1 (en) * | 2020-01-20 | 2020-10-06 | ООО "Фитолон-Наука" | Composition in form of gel for oral tissues care |
CN111733597B (en) * | 2020-06-02 | 2023-05-02 | 苏州工业园区安诺科斯化妆品研发有限公司 | Mask deodorant and preparation method thereof |
WO2022019319A1 (en) * | 2020-07-21 | 2022-01-27 | 株式会社トレスバイオ研究所 | Antimicrobial agent and method for manufacturing same |
KR102492710B1 (en) * | 2020-11-05 | 2023-01-26 | 송운서 | Disposable antibacterial swab and manufacturing method thereof |
US20220395450A1 (en) * | 2021-06-10 | 2022-12-15 | Pauleine Prospere | Hair Or Skin Treatment Composition And Methods Of Preparation And Use |
CN113598354A (en) * | 2021-08-11 | 2021-11-05 | 广元九道梁食品有限公司 | Amorphophallus rivieri vegetarian tripe and preparation method thereof |
CN113712051A (en) * | 2021-10-20 | 2021-11-30 | 台州诺洁日用品有限公司 | Plant bacteriostatic agent composition and application thereof |
WO2023111093A1 (en) * | 2021-12-15 | 2023-06-22 | Purac Biochem B.V. | Concentrates and preservative compositions prepared therefrom |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5073366A (en) * | 1989-05-30 | 1991-12-17 | Fred Beck | Analgesic composition useful in providing a temporary relief from symptoms of arthritis |
US5135747A (en) * | 1991-05-17 | 1992-08-04 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Deodorant/antiperspirant products with fragrance and encapsulated odor counteractant |
US20090191288A1 (en) * | 1996-02-12 | 2009-07-30 | Squires Meryl J | Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases |
JPH09323910A (en) * | 1996-06-03 | 1997-12-16 | Baasu Kk | Algicide having improving action on water quality and soil property |
US5891422A (en) * | 1996-10-10 | 1999-04-06 | Warner-Lambert Company | Antimicrobial composition containing a C3 -C6 alcohol |
EP0916718A1 (en) * | 1997-10-14 | 1999-05-19 | The Procter & Gamble Company | Cleaning and disinfecting compositions |
US6348501B1 (en) * | 1999-09-29 | 2002-02-19 | Medical Merchandising, Inc. | Lotion compositions utilizing capsaicin |
WO2001058263A1 (en) * | 2000-01-28 | 2001-08-16 | Greentech, Inc. | Compositions and methods for controlling pests using synergistic cocktails of plant alkaloids |
CA2408173A1 (en) * | 2000-05-26 | 2001-12-06 | The Procter & Gamble Company | Soap based pesticides |
JP2002193717A (en) * | 2000-12-28 | 2002-07-10 | Okada Giken:Kk | Antibacterial agent |
US20030113388A1 (en) * | 2001-12-13 | 2003-06-19 | Dung Phan | Methods of treatment for skin disorders using turmeric extract and a hydroxy acid |
US20030213168A1 (en) * | 2002-04-01 | 2003-11-20 | Anthony Hesse | Compositions, methods and devices for enhancing landscaping materials |
US20070292461A1 (en) * | 2003-08-04 | 2007-12-20 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
JP4687874B2 (en) * | 2005-02-16 | 2011-05-25 | 日本曹達株式会社 | Sustained release gel composition |
EA013056B1 (en) * | 2005-04-01 | 2010-02-26 | Ньюроджесэкс, Инк. | Oils of capsaicinoids and methods of making and using the same |
US20070014823A1 (en) * | 2005-07-12 | 2007-01-18 | The Procter & Gamble Company | Multi phase personal care composition comprising compositions having similar rheology profile in different phases |
US20080166314A1 (en) * | 2005-11-01 | 2008-07-10 | Juice Beauty | Compositions for juice-based treatment serums |
US20070190094A1 (en) * | 2006-01-10 | 2007-08-16 | Ecosmart Technologies, Inc. | Pesticidal compositions containing isopropyl-containing compounds as pesticidally active ingredients |
JP5025985B2 (en) * | 2006-04-27 | 2012-09-12 | 株式会社Adeka | Antibacterial agent and antibacterial composition containing the same |
US20080253976A1 (en) * | 2007-04-16 | 2008-10-16 | Douglas Craig Scott | Personal Care Compositions Comprising An Antimicrobial Blend of Essential Oils or Constituents Thereof |
US9687429B2 (en) * | 2007-06-20 | 2017-06-27 | The Trustees Of Columbia University In The City Of New York | Antimicrobial compositions containing low concentrations of botanicals |
KR100814420B1 (en) * | 2007-06-22 | 2008-03-18 | (주)목우연구소 | Uses of herbicidal 5-benzyloxymethyl-1,2-isoxazoline derivatives |
JP5398292B2 (en) * | 2009-02-10 | 2014-01-29 | ライオン株式会社 | Liquid detergent composition |
JP2010083806A (en) * | 2008-09-30 | 2010-04-15 | Kobayashi Pharmaceut Co Ltd | Sterilizing product contained in pressurized spray can |
AU2010232650A1 (en) * | 2009-03-31 | 2011-11-03 | Oms Investments, Inc. | Compositions for the masking of malodor in agricultural compositions and methods of making and using thereof |
JP2012532141A (en) * | 2009-06-30 | 2012-12-13 | ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク | Antimicrobial / preservative composition containing plant components |
-
2012
- 2012-05-09 CA CA2890395A patent/CA2890395C/en active Active
- 2012-05-09 JP JP2014539926A patent/JP2015501330A/en active Pending
- 2012-05-09 WO PCT/US2012/037135 patent/WO2013066403A1/en active Application Filing
- 2012-05-09 CN CN201280064657.3A patent/CN104039338A/en active Pending
- 2012-05-09 AU AU2012333187A patent/AU2012333187A1/en not_active Abandoned
- 2012-05-09 IN IN4034CHN2014 patent/IN2014CN04034A/en unknown
- 2012-05-09 EP EP12846062.3A patent/EP2775847A4/en not_active Ceased
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10806144B2 (en) | 2011-11-03 | 2020-10-20 | The Trustees Of Columbia University In The City Of New York | Composition with sustained antimicrobial activity |
CN111803696A (en) * | 2020-07-10 | 2020-10-23 | 中山大学 | Preparation method of patchouli oil nano composite membrane for skin wound repair |
CN111803696B (en) * | 2020-07-10 | 2022-02-18 | 中山大学 | Preparation method of patchouli oil nano composite membrane for skin wound repair |
Also Published As
Publication number | Publication date |
---|---|
CA2890395C (en) | 2021-03-16 |
WO2013066403A1 (en) | 2013-05-10 |
JP2015501330A (en) | 2015-01-15 |
AU2012333187A1 (en) | 2014-06-26 |
IN2014CN04034A (en) | 2015-10-23 |
CN104039338A (en) | 2014-09-10 |
CA2890395A1 (en) | 2013-05-10 |
EP2775847A4 (en) | 2016-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9968101B2 (en) | Botanical antimicrobial compositions | |
CA2890395C (en) | Botanical antimicrobial compositions | |
US10542760B2 (en) | Skin and surface disinfectant compositions containing botanicals | |
AU2010266325B2 (en) | Antimicrobial/preservative compositions comprising botanicals | |
US9687429B2 (en) | Antimicrobial compositions containing low concentrations of botanicals | |
US20130230609A1 (en) | Antimicrobial/preservative compositions comprising botanicals | |
US20090175806A1 (en) | Antimicrobial Compositions Containing Low Concentrations of Botanicals | |
AU2019200786B2 (en) | Antimicrobial/preservative compositions comprising botanicals | |
US20100172848A1 (en) | Skin and surface disinfectant compositions containing botanicals | |
WO2008157847A1 (en) | Skin and surface disinfectant compositions containing botanicals | |
WO2010091415A1 (en) | Antimicrobial compositions containing low concentrations of botanicals | |
CA2464468C (en) | Gentle-acting skin-disinfectants and hydroalcoholic gel formulations | |
US20160000094A1 (en) | Broad spectrum natural preservative composition | |
US20150265666A1 (en) | Botanical antimicrobial compositions | |
US9497975B2 (en) | Broad spectrum natural preservative composition | |
EP2970834A2 (en) | Broad spectrum natural preservative composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20140529 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A01N 31/04 20060101ALI20150806BHEP Ipc: A61Q 17/00 20060101ALI20150806BHEP Ipc: A61K 8/34 20060101ALI20150806BHEP Ipc: A01N 65/00 20090101AFI20150806BHEP Ipc: A61K 8/97 20060101ALI20150806BHEP Ipc: A61K 36/00 20060101ALI20150806BHEP Ipc: A61K 8/35 20060101ALI20150806BHEP Ipc: A01N 31/08 20060101ALI20150806BHEP |
|
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20151210 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61Q 17/00 20060101ALI20151204BHEP Ipc: A61K 36/00 20060101ALI20151204BHEP Ipc: A01N 31/04 20060101ALI20151204BHEP Ipc: A61K 8/97 20060101ALI20151204BHEP Ipc: A01N 65/00 20090101AFI20151204BHEP Ipc: A61K 8/34 20060101ALI20151204BHEP Ipc: A61K 8/35 20060101ALI20151204BHEP Ipc: A01N 31/08 20060101ALI20151204BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20180322 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20210425 |